| |
|
|
|
|
|||||||||||||||||||||||||||||||||||
![]() |
![]() |
|
|||||||||||||||||||||||||||||||||||||
![]() |
|
||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||
| |
|
||||||||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||||||
| |
MYELOPROLIFERATIVE DISORDERS (MPD) NEW INVESTIGATOR AWARDS Call for Proposals: July 2008
PROGRAM DESCRIPTION The MPD Foundation seeks proposals for the 2008 MPD New Investigator Awards program, an initiative supporting:
Applications for the MPD New Investigator Award Program are due October 15, 2008. The goal of this initiative is to expand the breadth of MPD research being conducted in academic institutions by encouraging new researchers and established scientists to engage in basic and translational research into causes and treatments of myeloproliferative disorders (MPDs). Proposals may request up to $75,000 including up to 8% indirect costs. Awards are anticipated to be in the range of $50,000 - $75,000 per year. Renewal of the grant for a second year will be based on satisfactory progress as determined through review by the Scientific Advisory Board of the MPD Foundation. KEY DATES Call for proposals July 1, 2008 Intent letter due date September 1, 2008 Proposal due date October 15, 2008 Notification of Awards No later than February 1, 2008 Anticipated funding start date April 1, 2009 (or later if required for IRB) APPLICATION PROCESS
Applicants for the MPD New Investigator awards are requested to submit their applications in two parts:
Printable instructions and application available here Both the Intent Letter and Full Proposal should be emailed to the attention of Michelle Woehrle at mwhoerle@mpdfoundation.org CRITERIA FOR EVALUATION Proposals will be reviewed by the MPD Scientific Advisory Board (SAB). In addition to the research scope, the SAB will weigh the probability of meaningful results from the proposed research, and the likely contribution of the research to the advancement of knowledge of MPDs.
|
|
|
||||||||||||||||||||||||||||||||||||
|
|